Table 2.
Association of clinical and demographic factors with mode of detection and severity at initial assessment
|
Outcome: symptom-based surveillance |
Outcome: moderate or severe assessment |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univariate regression |
Multivariate regression |
Univariate regression |
Multivariate regression |
|||||||||
| OR | 2·5% | 97·5% | OR | 2·5% | 97·5% | OR | 2·5% | 97·5% | OR | 2·5% | 97·5% | |
| Sex | ||||||||||||
| Female | Ref | .. | .. | Ref | .. | .. | Ref | .. | .. | Ref | .. | .. |
| Male | 3·23 | 1·93 | 5·53 | 3·06 | 1·77 | 5·44 | 1·30 | 0·82 | 2·07 | 1·37 | 0·85 | 2·22 |
| Age | ||||||||||||
| 0–9 years | 0·07 | 0·02 | 0·23 | 0·08 | 0·02 | 0·25 | 0·88 | 0·30 | 2·77 | 0·67 | 0·22 | 2·23 |
| 10–19 years | 0·19 | 0·05 | 0·77 | 0·17 | 0·04 | 0·76 | 1·08 | 0·28 | 5·27 | 0·88 | 0·22 | 4·40 |
| 20–29 years | 0·33 | 0·12 | 0·89 | 0·37 | 0·13 | 1·02 | 0·65 | 0·28 | 1·56 | 0·61 | 0·26 | 1·49 |
| 30–39 years | 0·75 | 0·31 | 1·77 | 0·8 | 0·32 | 1·93 | 1·17 | 0·58 | 2·37 | 1·15 | 0·57 | 2·33 |
| 40–49 years | 0·86 | 0·32 | 2·33 | 0·79 | 0·29 | 2·19 | 1·27 | 0·58 | 2·83 | 1·21 | 0·55 | 2·72 |
| 50–59 years | Ref | .. | .. | Ref | .. | .. | Ref | .. | .. | Ref | .. | .. |
| 60–69 years | 0·48 | 0·2 | 1·08 | 0·44 | 0·18 | 1·04 | 1·50 | 0·72 | 3·16 | 1·43 | 0·68 | 3·03 |
| ≥70 years | 0·56 | 0·16 | 2·25 | 0·45 | 0·12 | 1·89 | 1·41 | 0·45 | 5·43 | 1·28 | 0·40 | 4·96 |
| Severity | ||||||||||||
| Mild | Ref | .. | .. | Ref | .. | .. | .. | .. | .. | .. | .. | .. |
| Moderate | 0·6 | 0·33 | 1·05 | 0·51 | 0·26 | 0·94 | .. | .. | .. | .. | .. | .. |
| Severe | 2·2 | 0·68 | 9·84 | 1·51 | 0·42 | 7·23 | .. | .. | .. | .. | .. | .. |
| Fever | ||||||||||||
| No | Ref | .. | .. | .. | .. | .. | Ref | .. | .. | .. | .. | .. |
| Yes | 3·06 | 1·69 | 5·49 | .. | .. | .. | 0·94 | 0·49 | 1·75 | .. | .. | .. |
| Symptomatic | ||||||||||||
| No | Ref | .. | .. | .. | .. | .. | Ref | .. | .. | .. | .. | .. |
| Yes | 8·62 | 3·68 | 21·89 | .. | .. | .. | 0·51 | 0·15 | 1·39 | 0·55 | 0·29 | 1·01 |
| Surveillance method | ||||||||||||
| Contact-based | .. | .. | .. | .. | .. | .. | Ref | .. | .. | .. | .. | .. |
| Symptom-based | .. | .. | .. | .. | .. | .. | 0·67 | 0·37 | 1·17 | .. | .. | .. |
OR=odds ratio.